NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD
ReShape Lifesciences Inc. (RSLS) has a market capitalization of $2.34M and trades at $3.92. The 52-week range is 2.8-1212.99.
Key metrics include annual revenue of $319.71K.
The stock has a beta of 1.90, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
